| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,259 | 4,996 | 4,016 | 3,580 | | Cost of Revenue | 561 | 445 | 573 | 590 | | | Gross Profit | 4,698 | 4,551 | 3,443 | 2,990 | | | Operating Expenses | | Research Development | 1,249 | 2,032 | 2,164 | 2,179 | | Selling General and Administrative | 2,966 | 2,600 | 3,469 | 4,256 | | Non Recurring | 1,612 | 943 | 1,032 | 7,023 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,652) | (1,024) | (3,222) | (10,468) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (428) | 833 | 271 | 291 | | Earnings Before Interest And Taxes | (1,657) | (191) | (2,951) | (10,177) | | Interest Expense | (70) | 33 | 37 |
-
| | Income Before Tax | (1,587) | (224) | (2,988) | (10,177) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (918) | (224) | (2,988) | (10,177) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,587) | (224) | (2,988) | (10,177) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,587) | ($224) | ($2,988) | ($10,177) |
|
0.03% Nasdaq 
Income Statement
